
Jesse Lee Berry MD
Cataract Related, Retinal Disease, Ocular Oncology
Associate Professor, Ophthalmology, Clinical Scholar, Keck School of Medicine of the University of So California
Join to View Full Profile
4650 W Sunset BlvdLos Angeles, CA 90027
Phone+1 888-631-2452
Fax+1 323-442-6338
Dr. Berry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jesse Berry is an ophthalmologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including VA Greater Los Angeles Healthcare System, LAC+USC Medical Center, and Keck Hospital of USC. She received her medical degree from Harvard Medical School and has been in practice 9 years. She also speaks multiple languages, including Spanish. She specializes in ocular oncology and is experienced in treatment of retinoblastoma, uveal melanoma, ocular surface tumors, and other ophthalmic oncology surgery.
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 2009 - 2012
- Harvard Medical SchoolClass of 2008
- Harvard CollegeA.B., Biochemical Sciences. Minor in Spanish, Cum Laude, 2000 - 2004
Certifications & Licensure
- CA State Medical License 2009 - 2025
- AZ State Medical License 2016 - 2020
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Society of Heed Fellows 2013
- Excellence in Resident Teaching Award University of Southern California, 2013
- Heed Ophthalmic Foundation Fellow 2013
- Join now to see all
Publications & Presentations
PubMed
- "Safety Assessment of Aqueous Humor Liquid Biopsy in Retinoblastoma: A Multicenter Study of 1,203 Procedures".Douglas Chigane, Drishti Pandya, Muskaan Singh, Brianne Brown, Michelle Lin
Ophthalmology. 2025-03-19 - 2 citationsRetinoblastoma Outcomes Based on the 8th Edition American Joint Committee on Cancer Pathological Classification in 1411 Patients.Vijitha S Vempuluru, Carol L Shields, Jesse L Berry, Swathi Kaliki,
Ophthalmology. 2025-03-01 - NEOVASCULAR GLAUCOMA AS A PREDICTOR OF RETINOBLASTOMA HIGH-RISK HISTOPATHOLOGY IN AN INTERNATIONAL MULTICENTER STUDY.Guy S Negretti, Tatiana Ushakova, Serov Yuri, Polyakov Vladimir, Jesse L Berry
Retina. 2025-03-01
Journal Articles
- Outcomes of Medium-sized Choroidal Melanomas Treated with USC Eye Physics(R) Plaques: 20-year ReviewBerry JL, Dandapani SV, Stevanovic M, Astrahan M, Lee TC, Murphree AL, Kim JW, 9/5/2013
- Long term Outcomes of Group D Eyes in Bilateral Retinoblastoma Patients Treated with Chemoreduction and Low-dose IMRT SalvageBerry JL, Jubran R, Kim JW, Wong KE, Almarzouki H, Lee TC, Murphree AL, Pediatr Blood Cancer, 4/1/2013
- Los Angeles County-University of Southern California Residents Review: "Cataract Surgery with Trabecular Micro-bypass Stent Implantation in Patients with Mild-to-moder...Swamy R, Berry J, Huang A, Vazquez L, Eye World, 8/1/2012
- Join now to see all
Press Mentions
- How a New Test Is Transforming Care for RetinoblastomaDecember 12th, 2024
- Children’s Hospital Los Angeles Develops Liquid Biopsy Test for Pediatric Solid TumorsMarch 2nd, 2023
- Liquid Biopsy Test for Children’s Solid Tumors DevelopedMarch 2nd, 2023
- Join now to see all
Grant Support
- Validation of an aqueous humor liquid biopsy for molecular prognostication and monitoring of children with retinoblastoma.CHILDREN'S HOSPITAL OF LOS ANGELES2023–2028
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: